Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model

Thrombosis Research

Volumn 123, Issue SUPPL. 4, 2009, Pages

  Sud, Rohit ^a   Khorana, Alok A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Cancer; Risk factors; Venous thromboembolism

Indexed keywords

C REACTIVE PROTEIN; D DIMER; PADGEM PROTEIN; THROMBOPLASTIN;

AGE DISTRIBUTION; AMBULATORY CARE; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; COMORBIDITY; DISEASE ASSOCIATION; HEALTH CARE UTILIZATION; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MORBIDITY; NEOPLASM; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SOLID TUMOR; THERAPY DELAY; THROMBOCYTE COUNT; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BIOLOGICAL MARKERS; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS;

EID: 62249146845     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70137-9     Document Type: Article

References (16)

1. Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., and Lyman G.H. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5 (2007) 632-634
2. Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., and Lyman G.H. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110 (2007) 2339-2346
3. Prandoni P., Lensing A.W., Piccioli A., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100 (2002) 3484-3488
4. Khorana A.A., Francis C.W., Culakova E., and Lyman G.H. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104 (2005) 2822-2829
5. Khorana A.A., Francis C.W., Culakova E., Fisher R.I., Kuderer N.M., and Lyman G.H. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24 (2006) 484-490
6. Blom J.W., Doggen C.J., Osanto S., and Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293 (2005) 715-722
7. Fisher B., Dignam J., Wolmark N., et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89 (1997) 1673-1682
8. Bennett C.L., Schumock G.T., Desai A.A., et al. Thalidomide-associated deep vein thrombosis and pulmonary embolism. Am J Med 113 (2002) 603-606
9. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350 (2004) 2335-2342
10. Bohlius J., Wilson J., Seidenfeld J., et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98 (2006) 708-714
11. Sallah S., Husain A., Sigounas V., et al. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy. Clin Cancer Res 10 (2004) 7238-7243
12. Uno K., Homma S., Satoh T., et al. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96 (2007) 290-295
13. Khorana A.A., Ahrendt S.A., Ryan C.K., et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13 (2007) 2870-2875
14. Khorana A.A., Francis C.W., Menzies K.E., et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6 11 (2008 Nov) 1983-1985
15. Ay C., Simanek R., Vormittag R., et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 112 (2008) 2703-2708
16. Khorana A.A., Kuderer N.M., Culakova E., Lyman G.H., and Francis C.W. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111 (2008) 4902-4907